Enhancing In Vivo Electroporation Efficiency through Hyaluronidase: Insights into Plasmid Distribution and Optimization Strategies
Authors:
- Debnath MajiDMDebnath Maji
- Verónica MiguelaVMVerónica Miguela
- Andrew D. CameronACAndrew D. Cameron
- Delcora A. CampbellDCDelcora A. Campbell
- Linda SassetLSLinda Sasset
- Xin YaoXYXin Yao
- Andy T. ThompsonATAndy T. Thompson
- Carleigh SussmanCSCarleigh Sussman
- David YangDYDavid Yang
- Robert MillerRMRobert Miller
- Marek M. DrozdzMDMarek M. Drozdz
- Rachel A. LiberatoreRLRachel A. Liberatore
Open Access
- 17 April 2024
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (4) , 547
Abstract
Electroporation (EP) stands out as a promising non-viral plasmid delivery strategy, although achieving optimal transfection efficiency in vivo remains a challenge. A noteworthy advancement in the field of in vivo EP is the application of hyaluronidase, an enzyme with the capacity to degrade hyaluronic acid in the extracellular matrix, which thereby enhances DNA transfer efficiency by 2- to 3-fold. This paper focuses on elucidating the mechanism of hyaluronidase’s impact on transfection efficiency. We demonstrate that hyaluronidase promotes a more uniform distribution of plasmid DNA (pDNA) within skeletal muscle. Additionally, our study investigates the effect of the timing of hyaluronidase pretreatment on EP efficiency by including time intervals of 0, 5, and 30 min between hyaluronidase treatment and the application of pulses. Serum levels of the pDNA-encoded transgene reveal a minimal influence of the hyaluronidase pretreatment time on the final serum protein levels following delivery in both mice and rabbit models. Leveraging bioimpedance measurements, we capture morphological changes in muscle induced by hyaluronidase treatment, which result in a varied pDNA distribution. Subsequently, these findings are employed to optimize EP electrical parameters following hyaluronidase treatment in animal models. This paper offers novel insights into the potential of hyaluronidase in enhancing the effectiveness of in vivo EP, as well as guides optimized electroporation strategies following hyaluronidase use.Keywords
This publication has 60 references indexed in Scilit:
- Cole-impedance parameters representing biceps tissue bioimpedance in healthy adults and their alterations following eccentric exerciseJournal of Advanced Research, 2020
- Numerical optimization of plasmid DNA delivery combined with hyaluronidase injection for electroporation protocolComputer Methods and Programs in Biomedicine, 2020
- In Vivo Production of Monoclonal Antibodies by Gene Transfer via Electroporation Protects against Lethal Influenza and Ebola InfectionsMolecular Therapy - Methods & Clinical Development, 2017
- Optimizing hyaluronidase dose and plasmid DNA delivery greatly improves gene electrotransfer efficiency in rat skeletal muscleBiochemistry and Biophysics Reports, 2015
- Bioelectrical impedance analysis?part I: review of principles and methodsClinical Nutrition, 2004
- Intramuscular plasmid DNA electrotransferBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 2004
- Electroporation-Facilitated Delivery of Plasmid DNA in Skeletal Muscle: Plasmid Dependence of Muscle Damage and Effect of Poloxamer 188Molecular Therapy, 2001
- Electroporation-induced damage in mammalian cell DNABiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1995
- Electroporation: A general phenomenon for manipulating cells and tissuesJournal of Cellular Biochemistry, 1993
- Gene transfer into mouse lyoma cells by electroporation in high electric fields.The EMBO Journal, 1982